Castilla-La Mancha Promotes Genetic Research of the Esophagus
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM) is listed as an applicant and beneficiary entity proposed in the provisional resolution of the Instituto de Salud Carlos III (ISCIII) to receive 75,000 euros to investigate eosinophilic esophagitis. The project will be developed from the General Hospital of Tomelloso. Led by Emilio José Laserna Mendieta, the Research Unit of the hospital and the EIMIRlab group of IDISCAM, t…
The Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM) plans to finance 75,000 euros from the Carlos III Institute of Health for a study on eosinophilic esophagitis. The project will be developed from the General Hospital of Tomelloso (Ciudad Real). The study will analyze some 650,000 variants of DNA, together with clinical data of patients. The aim is to anticipate from the diagnosis how this chronic disease will evolve and ad…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
